Clinical Trial Update: Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT) [Phase 3]

View source ↗

Summary

Phase 3 open-label trial comparing telaprevir added to pegylated interferon and ribavirin versus pegylated interferon and ribavirin alone in hepatitis C genotyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 3 | Status: COMPLETED